Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn McGuire

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neurology|November 13, 2009
CSF biomarkers in HIV dementia: through a glass darklyDawn McGuire
Neurology|September 26, 2007
Black substanceDawn McGuire
AIDS (London, England)|December 13, 2001
Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementiaLeonard Kusdra, Dawn McGuire, Lynn Pulliam
Cerebrospinal Fluid Research|June 2, 2006
Elevated cerebrospinal fluid pressure in patients with Alzheimer's diseaseGerald Silverberg, Martha Mayo, Thomas Saul, et al.
The Lancet. Neurology|July 25, 2003
Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesisGerald D Silverberg, Martha Mayo, Thomas Saul, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkersGerald D Silverberg, Martha Mayo, Thomas Saul, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2011
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial designEdward Fox, Daniel Wynn, Stanley Cohan, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2004
Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patientsDomenico Praticò, Yuemang Yao, Joshua Rokach, et al.
Arthritis Research & Therapy|September 18, 2021
Study TPX-100-5: intra-articular TPX-100 significantly delays pathological bone shape change and stabilizes cartilage in moderate to severe bilateral knee OADawn McGuire, Michael Bowes, Alan Brett, et al.
Journal of Clinical Pharmacology|June 24, 2003
Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patientsDaniel Wermeling, Michael Drass, David Ellis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurology|November 13, 2009
CSF biomarkers in HIV dementia: through a glass darklyDawn McGuire
Neurology|September 26, 2007
Black substanceDawn McGuire
AIDS (London, England)|December 13, 2001
Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementiaLeonard Kusdra, Dawn McGuire, Lynn Pulliam
Cerebrospinal Fluid Research|June 2, 2006
Elevated cerebrospinal fluid pressure in patients with Alzheimer's diseaseGerald Silverberg, Martha Mayo, Thomas Saul, et al.
The Lancet. Neurology|July 25, 2003
Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesisGerald D Silverberg, Martha Mayo, Thomas Saul, et al.
Expert Review of Neurotherapeutics|April 28, 2005
Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkersGerald D Silverberg, Martha Mayo, Thomas Saul, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 9, 2011
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial designEdward Fox, Daniel Wynn, Stanley Cohan, et al.
Journal of Alzheimer'S Disease : JAD|September 4, 2004
Reduction of brain lipid peroxidation by CSF drainage in Alzheimer's disease patientsDomenico Praticò, Yuemang Yao, Joshua Rokach, et al.
Arthritis Research & Therapy|September 18, 2021
Study TPX-100-5: intra-articular TPX-100 significantly delays pathological bone shape change and stabilizes cartilage in moderate to severe bilateral knee OADawn McGuire, Michael Bowes, Alan Brett, et al.
Journal of Clinical Pharmacology|June 24, 2003
Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patientsDaniel Wermeling, Michael Drass, David Ellis, et al.
Pageof 2